Archive

New York City, New York – On December 5, 2016 OmniActive Health Technologies, Ltd. (OmniActive®) and Kemin Industries, Inc. (Kemin®) resolved their legal differences, placing the importance of human health above litigation. Both parties will withdraw all legal complaints, cross license each other’s “use patents” and begin to form a Lutein and Zeaxanthin Trade Organization.

“With this agreement, Kemin and OmniActive agree to cross license our current and future ‘use patents’ on lutein, zeaxanthin and their isomers, worldwide and royalty free,” said Sanjaya Mariwala, Managing Director & CEO of OmniActive Health Technologies. “This agreement removes patent road blocks, unleashes Kemin’s and OmniActive’s innovation for our customers worldwide and helps elevate the global usage of carotenoids.”

“Litigation brought us together to find common ground. We see great value in eliminating lutein and zeaxanthin deficiencies in the human population to optimize human health through nutritional guidance. To do this Kemin and OmniActive jointly commit to advancing the science supporting the human health benefits of carotenoids,” said Dr. Chris Nelson, President and CEO of Kemin Industries Inc.

“The first step to ensuring global alignment is to create a Lutein and Zeaxanthin Trade Organization to further Lutein and Zeaxanthin research and education for all population groups across the world. The organization will be open to all industry members,” said Mariwala. The details outlining the organization will be mapped out in the near future.

“The world is evolving, the importance of supplementation is growing, and Kemin and OmniActive are both committed to helping improve the health of our families through combined innovation and discovery,” said Nelson.

About Kemin® – Inspired Molecular Solutions™

Kemin (https://www.kemin.com/) provides “inspired molecular solutions” specifically developed to provide nutrition and health benefits for humans and animals. Committed to feed and food safety, Kemin maintains top-of-the-line manufacturing facilities where approximately 500 specialty ingredients are made for the global feed and food industries as well as the health, nutrition and beauty markets. A privately held, family-owned and operated company, Kemin has nearly 2,000 employees and operates in 90 countries with manufacturing facilities in Belgium, Brazil, China, India, Italy, Singapore, South Africa and the United States.

Kemin® is a registered trademark of Kemin Industries, Inc.

About OmniActive Health Technologies, Ltd.

OmniActive Health Technologies (www.omniactives.com) offers a range of quality ingredients, that are innovative and scientifically validated to address complex challenges for customers in the dietary supplement, food and beverage space using technology-driven, sustainable solutions with application support within a global regulatory framework.  OmniActive’s core products include carotenoids, plant extracts and specialty functional ingredients.  The company develops IP-protected, science-backed branded ingredients from natural sources using cutting edge technologies. OmniActive leverages international R&D strengths to deploy an array of state of the art manufacturing technologies in extraction, purification, isolation and delivery of nutritional actives.  Clinical research – geared towards demonstrating efficacy and claim substantiation – is the cornerstone of OmniActive’s R&D activities.  The company’s centers of excellence are located in North America and India, whereas its company’s cGMP and HACCP system-compliant manufacturing operations are located at multiple sites in India.  Whether looking for a new ingredient to add to a finished product, or technology to enhance an existing ingredient, OmniActive delivers unmatched innovation.

OmniActive® is a registered trademark of OmniActive Health Technologies.

For media inquiries, please contact:

Stacy Dill, World Wide Marketing Director | Kemin Human Nutrition & Health
949-350-3360, stacy.dill@kemin.com

Lynda Doyle, Sr. Vice President Global Marketing | OmniActive Health Technologies
866-588-3629, l.doyle@omniactives.com